D
Diana Priscila Penso Pires
Researcher at University of Minho
Publications - 32
Citations - 1785
Diana Priscila Penso Pires is an academic researcher from University of Minho. The author has contributed to research in topics: Biofilm & Bacteriophage. The author has an hindex of 11, co-authored 26 publications receiving 1163 citations. Previous affiliations of Diana Priscila Penso Pires include Massachusetts Institute of Technology.
Papers
More filters
Journal ArticleDOI
Genetically Engineered Phages: a Review of Advances over the Last Decade
Diana Priscila Penso Pires,Diana Priscila Penso Pires,Sara Cleto,Sanna Sillankorva,Joana Azeredo,Timothy K. Lu +5 more
TL;DR: This review highlights advances in techniques used to engineer phages as vehicles for drug delivery and vaccines, as well as for the assembly of new materials, and discusses existing challenges and opportunities.
Journal ArticleDOI
Bacteriophage-encoded depolymerases: their diversity and biotechnological applications
Diana Priscila Penso Pires,Hugo Alexandre Mendes Oliveira,Luís Daniel Rodrigues Melo,Sanna Sillankorva,Joana Azeredo +4 more
TL;DR: This is the first review gathering information about all the depolymerases encoded by fully sequenced phages, which can comprise areas as diverse as medical, chemical, or food-processing industry.
Journal ArticleDOI
Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing
TL;DR: In this article, a synthetic-biology strategy to modulate phage host ranges by engineering phage genomes in Saccharomyces cerevisiae was presented, and the synthetic phages achieved efficient killing of their new target bacteria and were used to selectively remove bacteria from multi-species bacterial communities with cocktails based on common viral scaffolds.
Journal ArticleDOI
Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections.
TL;DR: The studies involving the use of phages for the treatment or prevention of bacterial biofilms are summarized, highlighting the biofilm features that can be tackled with phages or combined therapy approaches.
Journal ArticleDOI
Phage Therapy: Going Temperate?
TL;DR: Advances in sequencing technologies and synthetic biology are providing new opportunities to explore the use of temperate phages for therapy against bacterial infections, and by doing so can considerably expand the armamentarium against the escalating threat of antibiotic-resistant bacteria.